Skip to content

Clinical trials

Observational Pulmonary Arterial Hypertension trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Arterial Hypertension Phase: Observational Country / region: China Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20101
20121
20131
20172
20181
20192
20211
20223
20231
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting8
Unknown status6
Active, not recruiting2
Completed2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese Pulmonary Vascular Disease Research Group3
RenJi Hospital2
Wuhan Asia Heart Hospital2
Actelion1
China-Japan Friendship Hospital1
Chinese Academy of Medical Sciences, Fuwai Hospital1
ChromX Health1
Guangdong Provincial People's Hospital1
Hong Liu1
Nanjing First Hospital, Nanjing Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Arterial Hypertension19
Hypertension, Pulmonary8
Disease2
Pulmonary Embolism2
Asthma1
Bronchiectasis1
Bronchitis1
Cystic Fibrosis1
Death1
Emphysema1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.